Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Internet Explorer is no longer a supported browser.

This website may not display properly with Internet Explorer. For the best experience, please use a more recent browser such as the latest versions of Google Chrome, Microsoft Edge, and/or Mozilla Firefox. Thank you.

Your Environment. Your Health.

University of Arizona

Superfund Research Program

Cardiac Teratogenicity of Halogenated Hydrocarbons

Project Leader: Paula D. Johnson
Grant Number: P42ES004940
Funding Period: 1995 - 2000

Learn More About the Grantee

Visit the grantee's eNewsletter page Visit the grantee's eNewsletter page Visit the grantee's Twitter page Visit the grantee's Instagram page Visit the grantee's Facebook page Visit the grantee's Video page

Project Summary (1995-2000)

A dose response study of the teratogenic potential of chlorinated hydrocarbons is being continued and identification/examination of several molecular markers as indicators of cardiac teratogenesis is being pursued in this study. Several molecules, known to be critical for normal heart development, are being examined in animals or cardiac cell cultures exposed to chlorinated hydrocarbons to determine whether regulation of gene expression is affected during cardiogenesis. Further, comparative gene amplification (differential display polymerase chain reaction), is being used to identify other genes that are specifically perturbed by exposure to chlorinated hydrocarbons. Once indicator molecules have been identified, there will be several significant advantages to this molecular approach. Each marker probe can be used for dose-sensitivity studies to identify critical threshold levels of exposure to the teratogens. Comparison between different strains of experimental animals can be used to address differences in sensitivity to teratogens in different genetic backgrounds. These probes can also be used in studies of normal heart development. Probes that prove to be reliable indicators of teratogen exposure can be used to identify the human homologue of these genes and may eventually be used as indicators in exposed human populations. Such probes may also be used to assess the effects of various remediation protocols.

Back
to Top